Skip to main content
Clinical Trials/NCT03402672
NCT03402672
Completed
Not Applicable

A Web-based E-health Application for Active Illicit Opioid Users Providing Information About Overdose and Infection Risk Factors and Encouraging HCV/HIV Testing and Medication Assisted Treatment Seeking

University of Cincinnati1 site in 1 country24 target enrollmentNovember 8, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Opioid-use Disorder
Sponsor
University of Cincinnati
Enrollment
24
Locations
1
Primary Endpoint
3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT)
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

The purpose of this research study is to:

  1. assess how participants like the AWAITS e-health application as measured by their feedback on the intervention
  2. test the impact of AWAITS on knowledge about opioid overdose and risk-reduction strategies.
  3. assess the proportion of participants who accept a list of local treatment providers
  4. test the impact of AWAITS on interest in being tested for HCV/HIV.

Detailed Description

The pre-post study of AWAITS will: 1) assess the acceptability of AWAITS as measured by participant feedback about the intervention; 2) test the impact of AWAITS on knowledge about opioid overdose, as measured by the OOTAS; 3) assess the proportion of participants who accept a list of local MAT treatment providers; and 4) test the impact of AWAITS on interest in being tested for HCV/HIV. The acceptability of AWAITS will be assessed with a feedback form which includes questions about how helpful the intervention was (scale of 1-4), what the patient liked most and least about the intervention, and any suggestions for improving it. The average (and standard deviation) for the rated helpfulness of the intervention will be derived and the qualitative data about what they liked most and least about the intervention and suggestions for improvement will be tabulated. Pre-/post-changes in the percent of correct knowledge assessment items (i.e., about overdose and MAT) and interest in HCV/HIV testing will be analyzed using a Wilcoxon signed-rank test. The proportion of participants accepting a list of local MAT treatment providers will be calculated.

Registry
clinicaltrials.gov
Start Date
November 8, 2017
End Date
June 21, 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Theresa Winhusen, PhD

Principal Investigator

University of Cincinnati

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age
  • Not enrolled in MAT per self-report
  • Self-reports illicit opioid use

Exclusion Criteria

  • Does not acknowledge reviewing "Information Sheet for Research" within REDCap

Outcomes

Primary Outcomes

3 sections of the OOTAS (signs of overdose, how to respond to an overdose, and MAT)

Time Frame: Day 1

To test the impact of AWAITS on knowledge about opioid overdose

Secondary Outcomes

  • Feedback on AWAITS(Day 1)
  • Acceptance of list of MAT providers(Day 1)

Study Sites (1)

Loading locations...

Similar Trials